Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holly Hagan

Showing results (1-10 of 175) with videos related to

Pageof 18
Sort By:
The Journal of Infectious Diseases|October 21, 2011
Agent, host, and environment: hepatitis C virus in people who inject drugsHolly Hagan
AIDS (London, England)|March 28, 2003
The relevance of attributable risk measures to HIV prevention planningHolly Hagan
Epidemiology (Cambridge, Mass.)|September 23, 2003
Does bleach disinfection of syringes help prevent hepatitis C virus transmission?Holly Hagan, Hanne Thiede
Substance Use & Misuse|February 10, 2011
Introduction: The New York HIV-drug use epidemic: lessons learned and unresolved issuesSherry Deren, Holly Hagan
The International Journal on Drug Policy|December 4, 2019
What is a rural opioid risk and policy environment?Richard A Jenkins, Holly Hagan
Antiviral Therapy|July 21, 2004
Highly active antiretroviral therapy for injection drug users: physician-recommended strategies for enhanced adherenceZdravko P Vassilev, Holly Hagan
Journal of General Internal Medicine|May 25, 2023
Exploring Barriers and Facilitators to Integrating a Harm Reduction Approach to Substance Use in Three Medical SettingsZoe Lindenfeld, Holly Hagan, Ji Eun Chang
Drug and Alcohol Dependence|September 2, 2009
Serosorting for hepatitis C status in the sharing of injection equipment among Seattle area injection drug usersRichard D Burt, Hanne Thiede, Holly Hagan
Substance Use & Misuse|March 27, 2013
Sexual HIV/HSV-2 risk among drug users in New York City: an HIV testing and counseling interventionMarlene Pantin, Noelle R Leonard, Holly Hagan
Journal of the American Board of Family Medicine : JABFM|May 11, 2023
Integrating Harm Reduction into Medical Care: Lessons from Three ModelsJi Eun Chang, Zoe Lindenfeld, Holly Hagan
Pageof 18

Showing results (1-10 of 175) with videos related to

Sort By:
Pageof 18
The Journal of Infectious Diseases|October 21, 2011
Agent, host, and environment: hepatitis C virus in people who inject drugsHolly Hagan
AIDS (London, England)|March 28, 2003
The relevance of attributable risk measures to HIV prevention planningHolly Hagan
Epidemiology (Cambridge, Mass.)|September 23, 2003
Does bleach disinfection of syringes help prevent hepatitis C virus transmission?Holly Hagan, Hanne Thiede
Substance Use & Misuse|February 10, 2011
Introduction: The New York HIV-drug use epidemic: lessons learned and unresolved issuesSherry Deren, Holly Hagan
The International Journal on Drug Policy|December 4, 2019
What is a rural opioid risk and policy environment?Richard A Jenkins, Holly Hagan
Antiviral Therapy|July 21, 2004
Highly active antiretroviral therapy for injection drug users: physician-recommended strategies for enhanced adherenceZdravko P Vassilev, Holly Hagan
Journal of General Internal Medicine|May 25, 2023
Exploring Barriers and Facilitators to Integrating a Harm Reduction Approach to Substance Use in Three Medical SettingsZoe Lindenfeld, Holly Hagan, Ji Eun Chang
Drug and Alcohol Dependence|September 2, 2009
Serosorting for hepatitis C status in the sharing of injection equipment among Seattle area injection drug usersRichard D Burt, Hanne Thiede, Holly Hagan
Substance Use & Misuse|March 27, 2013
Sexual HIV/HSV-2 risk among drug users in New York City: an HIV testing and counseling interventionMarlene Pantin, Noelle R Leonard, Holly Hagan
Journal of the American Board of Family Medicine : JABFM|May 11, 2023
Integrating Harm Reduction into Medical Care: Lessons from Three ModelsJi Eun Chang, Zoe Lindenfeld, Holly Hagan
Pageof 18